© 2021 Osprey Medical Inc. All rights reserved.
Osprey Medical, DyeVert, DyeMINISH, and Be Kind to Kidneys are registered trademarks of Osprey Medical, Inc. in the United States and other countries.
Releases
| Title | Date | Size | View |
|---|---|---|---|
| ASX ANNOUNCEMENT – Results of Special Meeting of Stockholders | September 3, 2021 | 229 KB | Download |
| Consolidation/Split – OSP | August 20, 2021 | 25 KB | Download |
| Notice of Special Meeting of Stockholders | August 20, 2021 | 573 KB | Download |
| Global expansion strategy progress strengthens revenues in the first half of 2021 | August 17, 2021 | 299 KB | Download |
| Half-Year Information for Six Months Ended 30 June 2021 | August 17, 2021 | 467 KB | Download |
| Martin Emerson appointed to Osprey Medical’s Board of Directors | August 12, 2021 | 178 KB | Download |
| Osprey continues to deliver positive results through strategic distribution agreements | July 29, 2021 | 537 KB | Download |
| Quarterly Results and Investor Conference Call Notification | July 22, 2021 | 225 KB | Download |
| Osprey expands into Canada with MDL approval and exclusive GE Healthcare distribution agreement | July 20, 2021 | 262 KB | Download |
| Steven Brandt appointed to Osprey Medical’s Board of Directors | July 1, 2021 | 177 KB | Download |
| Results of 2021 Annual Meeting of Stockholders | May 11, 2021 | 261 KB | Download |
| Strong quarter for Osprey with continued growth in units and revenue | April 22, 2021 | 619 KB | Download |
| Notice of Annual Meeting of Stockholders | April 20, 2021 | 618 KB | Download |
| Quarterly Results and Investor Conference Call Notification | April 16, 2021 | 217 KB | Download |
| CEO Business Update Investor Presentation | April 16, 2021 | 18 MB | Download |
| Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations | March 30, 2021 | 252 KB | Download |
| Osprey expands US sales coverage | March 18, 2021 | 360 KB | Download |
| Osprey presents at ASX Small & Mid-Cap Conference and Oppenheimer Healthcare Conference | March 10, 2021 | 18 MB | Download |
| Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) | March 3, 2021 | 181 KB | Download |
| Osprey expands US sales coverage with new sales agency agreements | March 2, 2021 | 432 KB | Download |
| Osprey Medical Financial Results for FY2020 | February 26, 2021 | 250 KB | Download |
| Funding Update – Exercise of Options and PPP Loan | February 23, 2021 | 181 KB | Download |
| Notice of Final Exercise of Options and Underwriting Arrangements | February 12, 2021 | 474 KB | Download |
| 4C and Business Update | January 28, 2021 | 537 KB | Download |
| Quarterly Results and Investor Conference Call Notification | January 22, 2021 | 215 KB | Download |
| Osprey Investor Presentation | January 12, 2021 | 13 MB | Download |
| Osprey Investor Presentation | December 3, 2020 | 2 MB | Download |
| Osprey signs strategic sales agency agreement for new US region | November 26, 2020 | 288 KB | Download |
| Strong quarter for Osprey with milestone distribution agreements signed | October 29, 2020 | 529 KB | Download |
| Exercise of Options | October 21, 2020 | 176 KB | Download |
| Quarterly Results and Investor Conference Call Notification | October 21, 2020 | 213 KB | Download |
| Osprey receives Supplier Horizon Award from Premier Inc | September 29, 2020 | 239 KB | Download |
| Regional Health Care Group to distribute Osprey Medical kidney protection technology across Australia and New Zealand | September 24, 2020 | 261 KB | Download |
| Osprey to Present at the H.C. Wainwright 22nd Annual Global Investment Conference | September 15, 2020 | 211 KB | Download |
| Notice of Exercise of Options | September 14, 2020 | 177 KB | Download |
| Positive outlook following adjustments to COVID-19 | August 25, 2020 | 314 KB | Download |
| Appendix 4D Half-Year Report for the Six Months Ended 30 June 2020 | August 25, 2020 | 472 KB | Download |
| Resignation of Andy Jane from the Board of Directors | August 18, 2020 | 177 KB | Download |
| CE Marking received for core European product, DyeVert Power XT | August 13, 2020 | 312 KB | Download |
| GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI) | July 30, 2020 | 257 KB | Download |
| Positive traction in the Quarter that was defined by COVID-19 | July 28, 2020 | 536 KB | Download |
| Shortfall Placement Update and Quarterly Results Release Notification | July 15, 2020 | 227 KB | Download |
| Response to ASX Price Query | July 3, 2020 | 303 KB | Download |
| Results of 2020 Annual Meeting of Stockholders | June 19, 2020 | 227 KB | Download |
| 2020 Annual Meeting of Stockholders – Chairman’s Address and Presentation by President and CEO | June 19, 2020 | 11 MB | Download |
| Issue of Securities under Shortfall Placement | June 12, 2020 | 176 KB | Download |
| Appendix 2A: Application for quotation of +securities | June 12, 2020 | 279 KB | Download |
| Appendix 3G: Notification of issue, conversion or payment up of equity +securities | June 12, 2020 | 381 KB | Download |
| Notice of Exercise of Options | June 10, 2020 | 368 KB | Download |
| Osprey Medical successfully raises an additional $2.6m under Shortfall Placement | June 9, 2020 | 179 KB | Download |
| Trading Halt | June 4, 2020 | 365 KB | Download |
| Notice of Annual Meeting of Stockholders | May 29, 2020 | 3 MB | Download |
| ASX Announcement | May 29, 2020 | 164 KB | Download |
| DyeVert™ featured at the SCAI 2020 Scientific Session: Procedure-Based Strategies to reduce Contrast-Induced Acute Kidney Injury | May 28, 2020 | 223 KB | Download |
| Allotment of Securities under Entitlement Offer | May 1, 2020 | 118 KB | Download |
| Appendix 2A: Application for quotation of +securities | May 1, 2020 | 156 KB | Download |
| Appendix 3G: Notification of issue, conversion or payment up of equity +securities | May 1, 2020 | 140 KB | Download |
| Quarterly Results and COVID-19 Update | April 30, 2020 | 253 KB | Download |
| Completion of Entitlement Offer | April 29, 2020 | 182 KB | Download |
| Osprey Medical Secures US Government COVID-19 Relief Loan | April 29, 2020 | 175 KB | Download |
| Quarterly Results and Investor Conference Call Notification | April 17, 2020 | 215 KB | Download |
| ASX ANNOUNCEMENT: 2020 Annual Meeting of Stockholders | April 16, 2020 | 235 KB | Download |
| Dispatch of Prospectus, Entitlement and Acceptance Forms | April 15, 2020 | 785 KB | Download |
| Rights Commence Trading | April 7, 2020 | 184 KB | Download |
| ASX ANNOUNCEMENT: Entitlement Offer – Notification to Ineligible CDI Holders and Optionholders | April 6, 2020 | 196 KB | Download |
| Amended and Restated Certificate of Incorporation | April 3, 2020 | 634 KB | Download |
| Osprey Medical Prospectus | April 3, 2020 | 489 KB | Download |
| Proposed Issues of Securities | April 3, 2020 | 42 KB | Download |
| Osprey Medical Announces Capital Raising and Trading Update | April 3, 2020 | 129 KB | Download |
| Trading Halt | April 1, 2020 | 354 KB | Download |
| Appendix 4G Corporate Governance Council | March 26, 2020 | 204 KB | Download |
| ASX ANNOUNCEMENT – 2020 Annual Meeting of Stockholders | March 26, 2020 | 196 KB | Download |
| 4E Cover Memo | February 25, 2020 | 103 KB | Download |
| Osprey Medical Financial Results for FY2019 | February 25, 2020 | 222 KB | Download |
| Appendix 4E (Rule 4.3A): Preliminary Final Report for the Year Ended 31 December 2019 | February 24, 2020 | 550 KB | Download |
| UK NICE Issues Positive MedTech Innovation Briefing on DyeVert™ | February 10, 2020 | 229 KB | Download |
| ASX ANNOUNCEMENT – 2020 Annual Meeting of Stockholders | February 6, 2020 | 197 KB | Download |
| Appendix 4C: Quarterly report for entities subject to listing rule 7.8B | February 5, 2020 | 69 KB | Download |
| 36% Increase in DyeVert Unit Sales | January 31, 2020 | 499 KB | Download |
| Amendment to Quarterly Results and Investor Conference Call Notification | January 21, 2020 | 220 KB | Download |
| Quarterly Results and Investor Conference Call Notification | January 10, 2020 | 215 KB | Download |
| Fourth Quarter Update | December 20, 2019 | 223 KB | Download |
| 48% Increase in DyeVert Third Quarter Unit Sales | October 29, 2019 | 459 KB | Download |
| Quarterly Results and Investor Conference Call Notification | October 17, 2019 | 275 KB | Download |
| Contrast-Induced Acute Kidney Injury Prevention Strategies Featured at TCT 2019 | October 3, 2019 | 278 KB | Download |
| Ceasing to be a Substantial Holder | September 6, 2019 | 65 KB | Download |
| Half Yearly Accounts Report | August 14, 2019 | 550 KB | Download |
| Half Year Info for Six Months ended 30 June 2019 | August 14, 2019 | 622 KB | Download |
| 64% Increase in DyeVert Second Quarter Unit Sales | July 15, 2019 | 262 KB | Download |
| Appendix 4C: Quarterly report for entities subject to Listing Rule 4.7B | July 15, 2019 | 169 KB | Download |
| US Government to Transform Kidney Care | July 12, 2019 | 277 KB | Download |
| Osprey Launches Educational Podcast Series for Investors | July 9, 2019 | 179 KB | Download |
| Quarterly Results and Investor Conference Call Notification | July 2, 2019 | 89 KB | Download |
| AKI Burden of Illness Data Presented at Premier® Breakthroughs Conference | June 21, 2019 | 311 KB | Download |
| Becoming a Substantial Holder | June 20, 2019 | 107 KB | Download |
| Ceasing to be a Substantial Holder | June 13, 2019 | 89 KB | Download |
| Osprey to Deliver AKI Burden of Illness Data to Premier QUEST® Hospitals | June 13, 2019 | 209 KB | Download |
| 2019 Annual Meeting of Stockholders – Chairman’s Address and Presentation by President and CEO | May 9, 2019 | 12 MB | Download |
| Results of 2019 Annual Meeting of Stockholders | May 9, 2019 | 344 KB | Download |
| DyeMINISH™ Multi-Centre Global Patient Registry Launched | May 8, 2019 | 251 KB | Download |
| Appendix 4C: Quarterly report for entities subject to Listing Rule 4.7B | April 17, 2019 | 169 KB | Download |
| 73% Increase in DyeVert First Quarter Unit Sales | April 17, 2019 | 319 KB | Download |
| Notice of Annual Meeting of Stockholders & Proxy Statement | April 11, 2019 | 3 MB | Download |
| Quarterly Results and Investor Conference Call Notification | April 8, 2019 | 237 KB | Download |
| Change in Substantial Holding | April 3, 2019 | 253 KB | Download |
| Appendix 4G | March 26, 2019 | 183 KB | Download |
| Significant DyeVert™ Clinical Data Featured at ACC and ACC Quality Summit Annual Meetings | March 20, 2019 | 289 KB | Download |
| Osprey Appoints Mr. Jim Surek as Vice President, Sales | March 4, 2019 | 241 KB | Download |
| Osprey Medical Preliminary Final Report and Consolidated Financial Statements | February 26, 2019 | 879 KB | Download |
| ASX ANNOUNCEMENT – 2019 Annual Meeting of Stockholders | February 1, 2019 | 292 KB | Download |
| Quarterly Cash Flow Report | January 29, 2019 | 438 KB | Download |
| Quarterly Results and Investor Conference Call Notification | January 17, 2019 | 307 KB | Download |
| Disclosure of Interests for Allan Gray Australia | December 10, 2018 | 258 KB | Download |
| Osprey Medical, Inc. Awarded Premier Purchasing Agreement for DyeVert™ PLUS Contrast Reduction System | December 3, 2018 | 272 KB | Download |
| Allotment of Securities under Entitlement Offer | November 30, 2018 | 130 KB | Download |
| Completion of Entitlement Offer | November 28, 2018 | 291 KB | Download |
| Entitlement Offer – Update on Shortfall | November 19, 2018 | 289 KB | Download |
| Entitlement Offer – Extension of Closing Date | November 13, 2018 | 301 KB | Download |
| Osprey Medical – Notice of despatch of entitlement offer documents | November 7, 2018 | 852 KB | Download |
| Osprey Medical Inc. Secondary Trading Notice: Notice given under Section 708A(5)(e) of the Corporations Act | November 6, 2018 | 347 KB | Download |
| Osprey Medical Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b) | November 6, 2018 | 325 KB | Download |
| Appendix 3B: New issue announcement, application for quotation of additional securities and agreement | November 6, 2018 | 403 KB | Download |
| Completion of Private Placement | November 6, 2018 | 293 KB | Download |
| Entitlement Offer – Notice to Holders of CDIs | October 31, 2018 | 382 KB | Download |
| Entitlement Offer – Notification to Ineligible CDI Holders | October 31, 2018 | 443 KB | Download |
| Entitlement Offer – Notice to Optionholders | October 30, 2018 | 109 KB | Download |
| Capital raising of up to A$20.5m to accelerate GPO-focused growth strategy | October 30, 2018 | 377 KB | Download |
| Quarterly Cash Flow Report | October 30, 2018 | 765 KB | Download |
| Offer Booklet | October 30, 2018 | 301 KB | Download |
| Appendix 3B: New issue announcement, application for quotation of additional securities and agreement | October 30, 2018 | 182 KB | Download |
| Notice given under Section 708AA(2)(f) of the Corporations Act | October 30, 2018 | 148 KB | Download |
| Letter to Option Holders | October 30, 2018 | 105 KB | Download |
| Quarterly Results and Investor Conference Call Notification | October 25, 2018 | 313 KB | Download |
| Acute Kidney Injury in the spotlight at the world’s largest international cardiovascular conference TCT 2018 | September 26, 2018 | 101 KB | Download |
| Osprey Medical and GE Healthcare Launch New Educational Program to Increase Awareness of Strategies to Help Address Acute Kidney Injury (AKI) | September 20, 2018 | 406 KB | Download |
| Osprey Medical begins market access process to approve DyeVert™ Plus System in UK | September 7, 2018 | 241 KB | Download |
| Half Yearly Accounts Report | August 27, 2018 | 344 KB | Download |
| Half Year Info for Six Months ended 30 June 2018 | August 27, 2018 | 301 KB | Download |
| Quarterly Cash Flow Report | July 19, 2018 | 1 MB | Download |
| Results of 2018 Annual Meeting of Stockholders | May 10, 2018 | 127 KB | Download |
| 2018 Annual Meeting of Stockholders – Chairman’s Address and Presentation by President and CEO | May 10, 2018 | 2 MB | Download |
| Strong Recovery for DyeVert Plus in April 2018 | May 2, 2018 | 96 KB | Download |
| DyeVert Plus Featured at SCAI 2018 Scientific Session | April 30, 2018 | 2 MB | Download |
| Quarterly Cash Flow Report | April 26, 2018 | 1.9 MB | Download |
| ASX ANNOUNCEMENT – Notice of 2018 Annual Meeting of Stockholders & Proxy Statement | April 9, 2018 | 1 MB | Download |
| Osprey Medical National Kidney Month Programs | March 21, 2018 | 1 MB | Download |
| Osprey Medical Preliminary Final Report and Consolidated Financial Statements | February 26, 2018 | 470 KB | Download |
| Osprey Study chosen for “Best of Best” Presentation at Society for Cardiovascular Angiography and Interventions conference | February 16, 2018 | 141 KB | Download |
| 2018 Annual Meeting of Stockholders Announcement | February 6, 2018 | 89 KB | Download |
| Quarterly Cash Flow Report | January 24, 2018 | 2 MB | Download |
| Osprey Medical Highlights from TCT 2017 | November 3, 2017 | 108 KB | Download |
| Quarterly Cash Flow Report | October 16, 2017 | 1 MB | Download |
| Issue of securities to complete Placement and Entitlement Offer | September 4, 2017 | 98 KB | Download |
| Osprey Medical Inc. Secondary Trading Notice: Notice given under Section 708A(5)(e) of the Corporations Act | September 4, 2017 | 119 KB | Download |
| Osprey Medical Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b) | September 4, 2017 | 126 KB | Download |
| Successful completion of A$10.3 million entitlement offer | August 30, 2017 | 114 KB | Download |
| Entitlement Offer Closing Date | August 22, 2017 | 102 KB | Download |
| Half Yearly Accounts Report | August 21, 2017 | 188 KB | Download |
| Half Year Information for the Six Months Ended 30 June 2017 | August 21, 2017 | 205 KB | Download |
| Appendix 3B: New issue announcement, application for quotation of additional securities and agreement | August 18, 2017 | 186 KB | Download |
| Osprey Medical Inc. Amended and Restated Certificate of Incorporation | August 16, 2017 | 1 MB | Download |
| Osprey Medical – Notice to Nominees | August 15, 2017 | 587 KB | Download |
| Osprey Medical – Notice of despatch of entitlement offer documents | August 14, 2017 | 1,010 KB | Download |
| Osprey Medical Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b) | August 11, 2017 | 134 KB | Download |
| Private Placement Update | August 11, 2017 | 100 KB | Download |
| Appendix 3B: New issue announcement, application for quotation of additional securities and agreement | August 11, 2017 | 204 KB | Download |
| Secondary Trading Notice: Notice given under Section 708A(5)(e) of the Corporations Act | August 11, 2017 | 121 KB | Download |
| Osprey Entitlement Offer – notification to ineligible CDI holders | August 7, 2017 | 625 KB | Download |
| Entitlement Offer – notice to holders of CDIs | August 7, 2017 | 546 KB | Download |
| Appendix 3B: New issue announcement, application for quotation of additional securities and agreement | August 4, 2017 | 197 KB | Download |
| Osprey Medical Announces Successful Oversubscribed Placement and Fully Underwritten Entitlement Offer | August 4, 2017 | 149 KB | Download |
| Osprey Medical Inc. Entitlement Offer – Notice to Optionholders | August 4, 2017 | 112 KB | Download |
| Osprey Medical Inc. Offer Booklet | August 4, 2017 | 381 KB | Download |
| Cleansing Document | August 4, 2017 | 182 KB | Download |
| Capital Raising Presentation, August 2017 | August, 2017 | 3.3 MB | Download |
| Capital Raise Trading Halt | August 2, 2017 | 334 KB | Download |
| Quarterly Cash Flow Report | July 13, 2017 | 1 MB | Download |
| Osprey Medical increases addressable market with new DyeTect™ Automated Contrast Monitoring System | July 3, 2017 | 156 KB | Download |
| Medtronic VP and GM Sandra Lesenfants Joins Osprey Board | June 20, 2017 | 137 KB | Download |
| ASX ANNOUNCEMENT – Results of 2017 Annual Meeting of Stockholders | May 18, 2017 | 137 KB | Download |
| ASX ANNOUNCEMENT – 2017 Annual Meeting of Stockholders – Chairman’s Address and Presentation by President and CEO | May 18, 2017 | 5 MB | Download |
| Quarterly Cash Flow Report | April 18, 2017 | 2 MB | Download |
| Osprey Medical Receives US FDA Clearance for DyeVert™ PLUS | March 9, 2017 | 371 KB | Download |
| ASX ANNOUNCEMENT – Notice of Annual Meeting of Stockholders & Proxy Statement | April 24, 2017 | 963 KB | Download |
| Preliminary Final Report and Consolidated Financial Accounts | February 27, 2017 | 290 KB | Download |
| CEO Presentation December 2016 | December 2016 | 2 MB | Download |
| Osprey Introduces DyeVert PLUS at TCT | November 2, 2016 | 370 KB | Download |
| Osprey to Present at TCT 2016 | October 26, 2016 | 288 KB | Download |
| 4C Quarterly Cash Flow Report | October 14, 2016 | 2 MB | Download |
| ASX ANNOUNCEMENT – Completion of Private Placement | September 9, 2016 | 92 KB | Download |
| Appendix 3B: New issue announcement, application for quotation of additional securities and agreement | September 9, 2016 | 219 KB | Download |
| Change of Melbourne Address for Shareholder Purposes | September 9, 2016 | 108 KB | Download |
| Form 604: Notice of Change of Interests of Substantial Holder | September 9, 2016 | 331 KB | Download |
| Brandon Capital Partners – Change in Substantial Holding | September 9, 2016 | 213 KB | Download |
| Secondary Trading Notice: Notice given under Section 708A(5)(e) of the Corporations Act | September 9, 2016 | 114 KB | Download |
| ASX ANNOUNCEMENT – Security Purchase Plan Scale Back | September 7, 2016 | 107 KB | Download |
| ASX ANNOUNCEMENT – Partial Allocation Under Tranche 2 of Placement and Security Purchase Plan Update | September 6, 2016 | 104 KB | Download |
| Notice Given Under Section 708A(5)(e) of the Corporations Act | September 6, 2016 | 113 KB | Download |
| Appendix 3B: New issue announcement, application for quotation of additional securities and agreement | September 6, 2016 | 207 KB | Download |
| Results of Special Meeting of Stockholders | August 30, 2016 | 136 KB | Download |
| Half Year Accounts Report | August 29, 2016 | 518 KB | Download |
| Appendix 4D Half Year Report & Accounts | August 26, 2016 | 195 KB | Download |
| Notice of Special Meeting of Stockholders | August 18, 2016 | 452 KB | Download |
| Cleansing Document | August 11, 2016 | 121 KB | Download |
| Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b) | August 11, 2016 | 107 KB | Download |
| Appendix 3B: New issue announcement, application for quotation of additional securities and agreement | August 11, 2016 | 216 KB | Download |
| Share Purchase Plan | August 3, 2016 | 619 KB | Download |
| Revised CEO Capital Raising Presentation | August 4, 2016 | 2 MB | Download |
| Capital Raising Presentation, August 2016 | August 2016 | 5 MB | Download |
| Amended and Restated Certificate of Incorporation | August 4, 2016 | 1 MB | Download |
| Osprey Medical Announces Oversubscribed A$28 Million Private Placement | August 4, 2016 | 124 KB | Download |
| Response to ASX Price Query | July 29, 2016 | 500 KB | Download |
| CommSec Interview with CEO Mike McCormick | July 27, 2016 | 241 KB | Download |
| Key Sales Milestones | July 7, 2016 | 108 KB | Download |
| DyeVert Pilot Results presented at EuroPCR | May 20, 2016 | 215 KB | Download |
| 2016 AGM Results | May 12, 2016 | 137 KB | Download |
| June 2016 Newsletter | June 2016 | 2 MB | Download |
| AGM Chairman’s letter and CEO presentation | May 12, 2016 | 5 MB | Download |